Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos to present at upcoming investor conferences
Investegate announcements from Galapagos NV, Galapagos to present at upcoming investor conferences
Source: investegate.co.uk
📰 Virtual Life Sciences News
Virtual Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Virtual Life Sciences. Real-time updates on events, politics, business and more.
Sensorion to Attend Two Conferences in June 2021
Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the
Nawal Ouzren Markus Metzger Lucy Codrington Professeur Joseph Blayac Sophie Baumont Head Of Investor Relations Corporate Communications
Source: finanznachrichten.de
SynAct Pharma: Interim report January-March 2021
The Groups profit before tax amounted to -14,070 ( -3,822) TSEK. The Groups earnings per share amounted to -0.46 (-0.14). The average number of shares for the period was 25,366,295. "SynAct Pharma AB" means the parent company SynAct Pharma AB with corporate registration number 559058-4826. The "Company" or "SynAct" means the Group, i.e. SynAct Pharma AB and its wholly owned subsidiary SynAct Pharma ApS. definitions Earnings per share: Profit for the period divided by the average number of shar...
Synact Thomas Boesen James Knight Thomas Jonassen Marina Bozilenko European Patent Office Company Or Synact
Source: realtid.se